KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
26.94
+0.07 (0.26%)
At close: Jun 1, 2026, 4:00 PM EDT
26.97
+0.03 (0.11%)
After-hours: Jun 1, 2026, 5:26 PM EDT
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $1.43 billion as of June 1, 2026. Its market cap has increased by 154.40% in one year.
Market Cap
1.43B
Enterprise Value
1.43B
1-Year Change
154.40%
Ranking
Category
Stock Price
$26.94
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $1.43B, an increase of 1,009.29%. That is a compound annual growth rate of 24.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.43B | 75.25% |
| Dec 31, 2025 | 816.30M | 95.01% |
| Dec 31, 2024 | 418.60M | -1.11% |
| Dec 29, 2023 | 423.30M | 154.39% |
| Dec 30, 2022 | 166.40M | -48.59% |
| Dec 31, 2021 | 323.70M | -4.99% |
| Dec 31, 2020 | 340.70M | 7.27% |
| Dec 31, 2019 | 317.60M | -6.64% |
| Dec 31, 2018 | 340.20M | 223.69% |
| Dec 29, 2017 | 105.10M | 690.23% |
| Dec 30, 2016 | 13.30M | -86.04% |
| Dec 31, 2015 | 95.30M | -26.30% |
| Apr 9, 2015 | 129.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MBX Biosciences | 1.50B |
| Ardelyx | 1.49B |
| Immunocore Holdings | 1.47B |
| Maze Therapeutics | 1.46B |
| Fortrea Holdings | 1.46B |
| Bicara Therapeutics | 1.43B |
| ArriVent BioPharma | 1.41B |
| MoonLake Immunotherapeutics | 1.40B |